News Headlines Article

Widely used special infant formula doesn’t work to protect against allergies, eczema, study says
Washington Post

In May 2011, the U.S. Food and Drug Administration approved a request by Nestle to be able to market its 100 percent whey-protein partially hydrolyzed infant formula as reducing the risk of eczema.

A new study, published in The BMJ that reviewed information from 37 different trials from 1946-2015, involving 19,000 participants, argues that may have been a mistake.